⌘K

Home/Filings/4/0001213900-21-014909

4//SEC Filing

Eisenberg Or 4

Accession 0001213900-21-014909

CIK 0001218683other

View on SEC.gov Company Profile

Filed

Mar 10, 7:00 PM ET

Accepted

Mar 11, 5:37 PM ET

Size

4.6 KB

Accession

0001213900-21-014909

Insider Transaction Report

Form 4

Period: 2021-03-09

Wize Pharma, Inc.WIZP

Acting CEO, CFO, Treas & Secy.

Transactions

Purchase
Common Stock, par value $0.001 per share
2021-03-09$0.12/sh+833,333$100,000→ 1,013,433 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Wize Pharma, Inc.

CIK 0001218683

Entity typeother

Related Parties

1

filerCIK 0001721412

Filing Metadata

Form type: 4
Filed: Mar 10, 7:00 PM ET
Accepted: Mar 11, 5:37 PM ET
Size: 4.6 KB

View on SEC.gov